Evidence map›Paper›PMID 41658518›Full record

ArticleFrontiers in endocrinology2026

Case Report: Investigation and characterization of a multiple endocrine neoplasia type 1 case and its pedigree.

Yifan Liu, Ling Cui, Shiwei Wang, Yanyan Chen, Ting Huang, Xin Hou

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yifan LiuClinical Medicine Department, The Second Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Ling CuiDepartment of Geriatric Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Shiwei WangDepartment of Pathology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Yanyan ChenDepartment of Geriatric Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Ting HuangDepartment of Geriatric Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Xin HouDepartment of Geriatric Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple Endocrine Neoplasia Type 1 (MEN1) is an autosomal dominant inherited disease characterized by the combined occurrence of tumors in multiple endocrine organs. As a rare disease, the clinical manifestations of MEN1 are currently considered to be associated with the development of combinations of more than 20 different tumors, such as parathyroid adenomas, neuroendocrine tumors, pituitary tumors, as well as lipomas, thymic carcinoids, pheochromocytomas, adrenal adenomas, and ovarian tumors. However, the concurrent occurrence of MEN1 and teratoma is extremely rare in reported cases to date. Herein, we report a case of a female patient with MEN1 who was diagnosed with teratoma. Genetic testing identified the NM_130799.2: c.512G>A (p.Arg171Gln) variant, which was classified as a variant of uncertain significance (VUS). After extracting whole blood DNA from the patient and her relatives (7 individuals in total) for genetic testing, this mutation was found to be present in multiple members of the family, including some who were affected by MEN1. This finding suggests the potential pathogenicity of the mutation, although further research and longer-term follow-up are required to confirm this observation.

Indexed as

Multiple Endocrine Neoplasia Type 1MutationTeratomaFemaleGenetic TestingHumansPedigreeProto-Oncogene ProteinsMEN1 protein, humanProto-Oncogene Proteinsc.512G>A variantcase reportgenetic testingmultiple endocrine neoplasia type 1pedigree

Identifiers

PMID41658518
PMCPMC12875917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.